1 – 10 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Establishment and Characterization of Innovative Immunoreagents for Diagnosis of Neurodegenerative Disease
(
- Master (Two yrs)
-
Mark
Exploring the potential of saruparib in overcoming venetoclax resistance in AML
(
- Master (Two yrs)
-
Mark
Diversity of Human Allergen-Specific IgE and Defining Epitope Recognition of Allergic Subjects that are to Undergo Allergen-Specific Immunotherapy
(
- Master (Two yrs)
-
Mark
Assay optimization for spatial omics analysis of oropharyngeal cancer tissue
(
- Master (Two yrs)
-
Mark
Towards Establishment of an Ex Vivo Bladder Tumor Model using Precision Cut Tumor Slices (PCTS) for Evaluation of Existing and Novel Treatments
(
- Master (Two yrs)
-
Mark
Prognostic impact of CD163 and CD11c in B cell lymphomas
(
- Master (Two yrs)
-
Mark
Variations in critical quality attributes (CQAs) on therapeutic monoclonal antibodies (mAbs) due to cultivation conditions, storage conditions and external stress-factors
(
- Master (Two yrs)
- 2023
-
Mark
The bispecific CD40xEpCAM antibody increase activation in human antigen presenting cell subsets and induce CD8+ T cell proliferation to a greater extent compared to monospecific antibodies
(
- Univ. Diploma
-
Mark
Characterization of SLC40A1 in Acute Myeloid Leukemia by CRISPRi Gene Editing
(
- Master (Two yrs)
-
Mark
Study of the immunological response from an OMV-based vaccine using ELISA
(
- Master (Two yrs)